ConvaTec Group Plc (CTEC) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

half-year 2025 ConvoTech results presentation. First, let me convey apologies from our CEO Karim, who is not feeling well today and won't be able to attend. So I am going to present his slides as well as the CFO section, and then I'll be very happy to take questions that anyone has afterwards. So the usual disclaimers apply. And the summary message for today is that we delivered a strong performance in the first half, financially and strategically, and we're on track to deliver our guidance. The highlights are on the slide. Revenue growth was, again, broad-based. Further operating margin expansion at the same rate as for the last three years. Second year of double digit EPS growth. Our product launches are progressing well. And so, as I said, we're on track to deliver guidance and that's for 2025 and for the medium term. Now these strong results in the first half demonstrate the resilience of our business model. We're not reliant on any one category or geography or product for our growth. At the core of that resilient business model is, first, that we operate in four chronic care categories. Growing structurally over time, we have strong market possessions with high levels of recurring revenue. And we expect to grow ahead of the markets consistently by virtue of our differentiated products and services. Second, we invest to develop those differentiated products and services, focusing in the fastest growing segments. and innovation is directed towards satisfying unmet customer needs, building customer loyalty and strong IP positions. We now have the richest product pipeline in the country's history and we achieved the target 30% vitality index one year early in 2024. Third, our growth is broad-based across diverse categories, geographies and products. Organic growth h...